Wang Ye, Gao Jing, Guo Xingdong, Tong Ti, Shi Xiaoshan, Li Lunyi, Qi Miao, Wang Yajie, Cai Mingjun, Jiang Junguang, Xu Chenqi, Ji Hongbin, Wang Hongda
State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China.
1] State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, China [2] University of Chinese Academy of Sciences, Beijing 100049, China.
Cell Res. 2014 Aug;24(8):959-76. doi: 10.1038/cr.2014.89. Epub 2014 Jul 8.
The abnormal activation of epidermal growth factor receptor (EGFR) is strongly associated with a variety of human cancers but the underlying molecular mechanism is not fully understood. By using direct stochastic optical reconstruction microscopy (dSTORM), we find that EGFR proteins form nanoclusters in the cell membrane of both normal lung epithelial cells and lung cancer cells, but the number and size of clusters significantly increase in lung cancer cells. The formation of EGFR clusters is mediated by the ionic interaction between the anionic lipid phosphatidylinositol-4,5-bisphosphate (PIP2) in the plasma membrane and the juxtamembrane (JM) region of EGFR. Disruption of EGFR clustering by PIP2 depletion or JM region mutation impairs EGFR activation and downstream signaling. Furthermore, JM region mutation in constitutively active EGFR mutant attenuates its capability of cell transformation. Collectively, our findings highlight the key roles of anionic phospholipids in EGFR signaling and function, and reveal a novel mechanism to explain the aberrant activation of EGFR in cancers.
表皮生长因子受体(EGFR)的异常激活与多种人类癌症密切相关,但其潜在的分子机制尚未完全明确。通过使用直接随机光学重建显微镜(dSTORM),我们发现EGFR蛋白在正常肺上皮细胞和肺癌细胞的细胞膜中均形成纳米簇,但肺癌细胞中簇的数量和大小显著增加。EGFR簇的形成是由质膜中阴离子脂质磷脂酰肌醇-4,5-二磷酸(PIP2)与EGFR的近膜(JM)区域之间的离子相互作用介导的。通过PIP2耗竭或JM区域突变破坏EGFR簇会损害EGFR激活和下游信号传导。此外,组成型活性EGFR突变体中的JM区域突变会减弱其细胞转化能力。总之,我们的研究结果突出了阴离子磷脂在EGFR信号传导和功能中的关键作用,并揭示了一种新机制来解释癌症中EGFR的异常激活。